Two Sigma Advisers’s XPeng XPEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,600
Closed -$377K 2194
2025
Q4
$377K Sell
18,600
-202,900
-92% -$4.4M ﹤0.01% 1893
2025
Q3
$5.19M Buy
221,500
+8,600
+4% +$173K 0.01% 737
2025
Q2
$3.81M Buy
+212,900
New +$4.16M 0.01% 840
2023
Q1
Sell
-3,096,500
Closed -$30.8M 2777
2022
Q4
$30.8M Buy
3,096,500
+1,719,800
+125% +$15.5M 0.09% 230
2022
Q3
$16.5M Buy
+1,376,700
New +$29.6M 0.05% 369
2022
Q2
Sell
-65,400
Closed -$1.8M 2904
2022
Q1
$1.8M Buy
+65,400
New +$2.32M ﹤0.01% 1323
2020
Q4
Sell
-23,500
Closed -$472K 2627
2020
Q3
$472K Buy
+23,500
New +$459K ﹤0.01% 1850

Other funds holding XPEV

Two Sigma Advisers's XPEV Position: Q1 2026 in Review

Two Sigma Advisers sold out of XPeng (XPEV) in Q1 2026, closing a stake of 18,600 shares — an estimated $377K sold.

Two Sigma Advisers first reported a position in XPEV in Q3 2020 and held it in 7 quarters. The position peaked at $30.8M in Q4 2022. 234 funds tracked by Wall St. Rank hold XPEV as of Q1 2026.

  • Two Sigma Advisers reported no remaining XPeng position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 18,600 XPeng shares in Q1 2026, an estimated $377K.
  • Two Sigma Advisers first reported a position in XPeng in Q3 2020 and held it in 7 quarters.
  • Two Sigma Advisers's XPeng position peaked at $30.8M in Q4 2022.
  • 234 funds tracked by Wall St. Rank held XPeng as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.